Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
3.6 USD -0.52 ( 12.57%)
Last update at 2026-11-06T21:14:00Z
VOLUME
13836
Market Cap
2.74M

Momentum Score

…

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.60
Low
3.80
High
52 Week Price Range
0.27
Low
2.89
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
4.12
Dividend Yield
-
Revenue TTM
12.07M
Revenue Per Share
1.46
Gross Profit TTM
4.23M
Debt / Equity
0.69
ROE
-115.07%
Net Debt
2.77M
ROCE
-38.09%
Diluted EPS TTM
-0.74

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.89M -3.46M -3.19M -4.75M -4.31M
Minority interest -0.11M 0.18M 0.03M - -
Net income -3.00M -3.28M -3.16M -6.14M -6.31M
Selling general administrative 7.86M 3.69M 2.96M 2.38M 2.54M
Selling and marketing expenses - 2.22M 0.44M 0.44M -
Gross profit 4.51M 2.75M 0.37M 0.26M 0.01M
Reconciled depreciation 0.74M 0.48M 0.32M 0.30M 0.11M
Ebit -2.86M -3.38M -3.17M -3.35M -2.57M
Ebitda -2.12M -2.90M -2.73M -3.04M -2.46M
Depreciation and amortization 0.74M 0.48M 0.44M 0.30M 0.11M
Operating income -3.35M -3.55M -3.48M -3.35M -2.57M
Other operating expenses 14.77M 12.24M 7.57M 5.40M 4.12M
Interest expense 0.03M 0.08M 0.01M 1.34M 2.00M
Tax provision 0.00M 0.00M 0.00M - -
Net interest income -0.03M -0.08M -0.01M -1.34M -2.00M
Income tax expense 0.11M -0.18M -0.03M 1.40M 2.00M
Total revenue 11.42M 8.69M 4.09M 2.05M 1.55M
Total operating expenses 7.86M 6.30M 3.85M 3.60M 2.58M
Cost of revenue 6.91M 5.94M 3.71M 1.79M 1.54M
Total other income expense net 0.46M 0.09M 0.29M -1.40M -1.74M
Net income from continuing ops -2.89M -3.46M -2.65M -4.75M -4.31M
Net income applicable to common shares - - - -4.75M -4.31M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 10.46M 10.98M 9.96M 10.36M 16.98M
Intangible assets 0.68M 0.81M 0.33M 0.02M 0.03M
Other current assets 1.24M 0.62M 0.40M 0.17M 0.08M
Total liab 5.57M 4.90M 4.79M 2.72M 4.90M
Total stockholder equity 4.46M 5.75M 4.70M 7.64M 12.09M
Other current liab 1.19M 0.61M 0.74M 0.37M 0.33M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -21.00M -18.00M -14.71M -11.56M -6.81M
Good will 1.13M 1.13M 1.13M 0.31M 0.31M
Other assets - - - 0.06M 0.06M
Cash 0.32M 1.81M 2.70M 1.10M 13.35M
Total current liabilities 2.96M 2.47M 2.55M 0.86M 2.89M
Current deferred revenue 0.00M 0.18M 0.02M - 0.05M
Net debt 2.77M 1.02M 0.10M 0.98M -9.09M
Short term debt 0.47M 0.39M 0.56M 0.22M 2.25M
Short long term debt 0.10M 0.10M 0.33M 0.01M 2.05M
Short long term debt total 3.09M 2.83M 2.80M 2.08M 4.26M
Other stockholder equity 25.45M 23.74M 19.41M 19.19M 18.89M
Property plant equipment - - - 2.46M 2.65M
Total current assets 4.34M 5.11M 5.05M 7.50M 13.93M
Long term investments 0.25M 0.00M - - -
Net tangible assets - - - 7.31M 11.74M
Short term investments - - 0.00M 5.51M -
Net receivables 0.67M 0.93M 0.63M 0.22M 0.21M
Long term debt 0.49M 0.59M 0.51M 0.27M 0.27M
Inventory 2.11M 1.75M 1.32M 0.50M 0.29M
Accounts payable 1.29M 1.29M 1.23M 0.27M 0.25M
Non currrent assets other 0.10M 0.10M 0.10M 0.06M 0.06M
Non current assets total 6.12M 5.87M 4.90M 2.85M 3.06M
Capital lease obligations 2.50M 2.14M 1.96M 1.80M 1.95M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00M -0.78M 5.20M -5.59M -0.27M
Change to liabilities - - - 0.01M -0.44M
Total cashflows from investing activities -0.07M -0.78M 4.46M -5.59M -0.27M
Net borrowings -0.16M 0.22M 0.38M -3.66M 2.98M
Total cash from financing activities 0.63M 3.75M 0.38M -3.66M 16.34M
Change to operating activities - - - -0.02M 0.04M
Net income -2.89M -3.28M -3.16M -4.75M -4.31M
Change in cash -0.75M -0.89M 1.60M -12.25M 13.32M
Begin period cash flow 1.81M 2.70M 1.10M 13.35M 0.03M
End period cash flow 1.06M 1.81M 2.70M 1.10M 13.35M
Total cash from operating activities -1.31M -3.87M -3.24M -2.99M -2.75M
Issuance of capital stock 0.96M 3.77M 0.00M 0.00M 13.47M
Depreciation 0.74M 0.48M 0.44M 0.30M 0.11M
Other cashflows from investing activities -0.07M -0.84M -0.50M - -
Change to inventory -0.36M -0.43M -0.76M -0.21M -0.06M
Change to account receivables 0.26M -0.30M -0.41M -0.01M -0.14M
Other cashflows from financing activities -0.18M -0.24M -0.17M -5.59M 2.98M
Change to netincome - - - 0.55M 0.10M
Capital expenditures 0.07M 0.44M 0.70M 0.10M 0.27M
Change in working capital 0.47M -1.17M -0.42M -0.23M -0.59M
Stock based compensation 0.65M 0.37M 0.22M 0.30M 0.28M
Other non cash items -0.28M -0.26M -0.32M 1.39M 1.98M
Free cash flow -1.38M -4.31M -3.93M -3.09M -3.02M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NXGL
Nexgel Inc
-0.52
12.57%
3.60 - 1.38 0.23 0.55 0.80 -0.85
ISRG
Intuitive Surgical Inc
-15.72
3.36%
452.80 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme
2.75
1.29%
215.85 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA
0.92
0.86%
107.77 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company
-1.69
0.79%
211.86 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Nexgel Inc

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

2150 Cabot Boulevard West, Langhorne, PA, United States, 19047

215 702 8550

19

Name Title Year Born
Mr. Adam R. Levy CEO, Pres & Director 1963
Mr. Adam E. Drapczuk III Chief Financial Officer 1976
Mr. David Stefansky Exec. Director 1971
Mr. Gregory Robb VP of Operations NA
Mr. Adam R. Levy CEO, President & Director 1963
Mr. Gregory Robb Vice President of Operations NA
Mr. Brian J. Kieser C.P.A. Interim CEO & Director 1967
Mr. Ian Blackman CPA Chief Financial Officer 1968
Mr. Gregory J. Robb Vice President of Operations NA
Mr. Valter Pinto Managing Director of KCSA Strategic Communications NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…